Vasomotor symptoms (Hot flashes/Night sweats)– Epidemiology Forecast—2032

January 2022 | 60 pages | ID: VA5262B05AD3EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Vasomotor symptoms (Hot flashes/Night sweats) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Vasomotor symptoms (Hot flashes/Night sweats) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Vasomotor symptoms (Hot flashes/Night sweats) Understanding

The DelveInsight Vasomotor symptoms (Hot flashes/Night sweats) epidemiology report gives a thorough understanding of the Vasomotor symptoms (Hot flashes/Night sweats) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Vasomotor symptoms (Hot flashes/Night sweats) in the US, Europe, and Japan. The report covers the detailed information of the Vasomotor symptoms (Hot flashes/Night sweats) epidemiology scenario in seven major countries (US, EU5, and Japan).

Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Perspective by DelveInsight

The Vasomotor symptoms (Hot flashes/Night sweats) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Vasomotor symptoms (Hot flashes/Night sweats) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Vasomotor symptoms (Hot flashes/Night sweats) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Vasomotor symptoms (Hot flashes/Night sweats) Detailed Epidemiology Segmentation

The Vasomotor symptoms (Hot flashes/Night sweats) epidemiology covered in the report provides historical as well as forecasted Vasomotor symptoms (Hot flashes/Night sweats) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Vasomotor symptoms (Hot flashes/Night sweats) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Vasomotor symptoms (Hot flashes/Night sweats) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Report and Model provide an overview of the global trends of Vasomotor symptoms (Hot flashes/Night sweats) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Vasomotor symptoms (Hot flashes/Night sweats) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Vasomotor symptoms (Hot flashes/Night sweats)
• The report provides the segmentation of the Vasomotor symptoms (Hot flashes/Night sweats) epidemiology

Report Highlights

• 11-year Forecast of Vasomotor symptoms (Hot flashes/Night sweats) epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Vasomotor symptoms (Hot flashes/Night sweats)
• Cases of Vasomotor symptoms (Hot flashes/Night sweats) by Mutation Types
• Vasomotor symptoms (Hot flashes/Night sweats) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Vasomotor symptoms (Hot flashes/Night sweats)?
• What are the key findings pertaining to the Vasomotor symptoms (Hot flashes/Night sweats) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Vasomotor symptoms (Hot flashes/Night sweats) across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Vasomotor symptoms (Hot flashes/Night sweats)?
• What are the currently available treatments of Vasomotor symptoms (Hot flashes/Night sweats)?

Reasons to buy

The Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Vasomotor symptoms (Hot flashes/Night sweats) market
• Quantify patient populations in the global Vasomotor symptoms (Hot flashes/Night sweats) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Vasomotor symptoms (Hot flashes/Night sweats) therapeutics in each of the markets covered
• Understand the magnitude of Vasomotor symptoms (Hot flashes/Night sweats) population by its epidemiology
• The Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF VASOMOTOR SYMPTOMS (HOT FLASHES/NIGHT SWEATS)

3. VASOMOTOR SYMPTOMS (HOT FLASHES/NIGHT SWEATS): DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Vasomotor symptoms (Hot flashes/Night sweats) Treatment and Management
6.2. Vasomotor symptoms (Hot flashes/Night sweats) Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in 7MM (2019-2032)
Table 2: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in the United States (2019-2032)
Table 4: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Germany (2019-2032)
Table 6: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in France (2019-2032)
Table 8: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Italy (2019-2032)
Table 10: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Spain (2019-2032)
Table 12: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in the United Kingdom (2019-2032)
Table 14: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Japan (2019-2032)
Table 16: Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in 7MM (2019-2032)
Figure 2 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in the United States (2019-2032)
Figure 4 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Germany (2019-2032)
Figure 6 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in France (2019-2032)
Figure 8 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Italy (2019-2032)
Figure 10 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Spain (2019-2032)
Figure 12 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in the United Kingdom (2019-2032)
Figure 14 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology in Japan (2019-2032)
Figure 16 Vasomotor symptoms (Hot flashes/Night sweats) Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report